Rodrigo Galindo‐Murillo
Ionis Pharmaceuticals (United States)
ORCID: 0000-0001-5847-4143Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Assessing the Current State of Amber Force Field Modifications for DNA─2023 Edition”.
Rodrigo Galindo‐Murillo, Marie Zgarbová, Jiřı́ Šponer, Petr Jurečka, Thomas E. Cheatham +1 more
Lauren Winkler, Juan Carlos García‐Ramos, Lena Ruíz-Azuara, Fernando Cortés‐Guzmán, Thomas E. Cheatham +1 more
Rodrigo Galindo‐Murillo, Thomas E. Cheatham, Lauren Winkler
Thomas E. Cheatham, Rodrigo Galindo‐Murillo
Rodrigo Galindo‐Murillo, Daniel R. Roe, Pablo D. Dans, Thomas E. Cheatham, Christina Bergonzo +1 more